ArticleJournal of managed care & specialty pharmacy2025
Pharmacist-supported electronic outreach to address medication nonadherence for Medicare Advantage enrollees.
Article in Journal of managed care & specialty pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of diabetes medication adherence quality measure performance with A1c control among Medicare Advantage beneficiaries.Journal of managed care & specialty pharmacy · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundImproved medication adherence, represented as an increase in the proportion of days covered (PDC), to chronic medications is associated with better patient outcomes, yet effective strategies to improve adherence are often resource intensive.
methodsThis retrospective cohort evaluation used mixed methods to assess the impact of a population health quality improvement program to address medication adherence for Medicare Advantage enrollees. The intervention was performed between January 1, 2023, and December 31, 2023, by population health teams supporting the University of Colorado Primary Care practices. The teams reviewed insurer-provided lists to identify patients late to refill a medication and sent an electronic health message, a mailed letter, or a phone call conveying concern for adherence. Patient responses requiring clinical intervention or education were triaged to clinical pharmacists for management per their clinical discretion. The proportion of Medicare Advantage enrollees classified as adherent, defined as PDC value of 0.8 or higher, was compared before (2022) and after implementation of the population-based outreach intervention for the 2023 plan year. Qualitative methods were used to evaluate patient response to electronic messages. The text of all patient replies to electronic messages was thematically analyzed and categorized.
resultsThe proportion of patients classified as adherent to diabetes medications was higher in the postintervention group (87.5%) compared with the preintervention group (83.4%,
conclusionsThe University of Colorado Medicine's population health initiative provided mixed results on medication adherence metrics. Electronic health record messaging provided insight into ways to improve the intervention to better engage and assist patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.